Investing Profile

Felice Verduyn - van Weegen

VCInvestor
Partner at EQT Group
eqtgroup.com/about/people/fel...Amsterdam, Netherlands
Photo of Felice Verduyn - van Weegen, Partner at EQT Group
Your Intro Paths to Felice Verduyn - van Weegen

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Felice is a member of
Hotmail Network
4883 CONNECTIONS
Mckinsey & Company Network
294 CONNECTIONS
Columbia University - Columbia Business School Network
176 CONNECTIONS
Harvard Medical School Network
52 CONNECTIONS
VU University Amsterdam Network
29 CONNECTIONS

Find Felice Verduyn - van Weegen on

cb
Current Investing Position
EQT Group Partner
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
8

Felice Verduyn - van Weegen is on these Sector & Stage Rankings

Felice Verduyn - van Weegen's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Noema Pharma
Series BDec 2024$150M
$260M
Co-investors: Nanna Luneborg (Forbion), Antoine Papiernik Papiernik (Sofinnova Partners)
Vico Therapeutics
Series BJan 2024$72M
Series AJul 2020$31M
$120M
Co-investors: Amy Schulman (Polaris Partners), Jean-François Rivassou (Kurma Partners), Martijn Kleijwegt (EQT Life Sciences), Silvia Noiman (Pontifax Venture Capital), Rémi Droller (Kurma Partners)
AgomAb Therapeutics
Series COct 2023$100M
$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Ohad Hammer (Xtripe Angels), Iyona Rajkomar (Pontifax Venture Capital)
Amolyt Pharma
Series CJan 2023$140M
Series BSep 2021$80M
$290M
Co-investors: Ohad Hammer (Xtripe Angels), Thierry Laugel (Kurma Partners), Iyona Rajkomar (Pontifax Venture Capital), Raphael Wisniewski (Andera Partners)
Egle Therapeutics
Series AOct 2021$47M
$47M
Co-investors: Jacques Mizrahi (Bioqube Ventures), Vincent Brichard
AM Pharma
Series FJul 2019$130M
$210M
Co-investors: Joël Jean-Mairet (Ysios Capital), Laia Crespo (Sanofi Ventures), Rémi Droller (Kurma Partners), Martijn Kleijwegt (EQT Life Sciences), Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion)

Felice Verduyn - van Weegen's Experience

Genetic and Twin Research Amsterdam Sustainability Institute - VU AmsterdamPresent
Genetic and Twin Research HotmailPresent
Genetic research fellow Harvard Medical SchoolPresent
Fellow Mckinsey & CompanyPresent
Investment Manager LSPPresent
Board Observer ONWARD MedicalPresent
Board Observer PharvarisPresent
Member Board Of Directors Amolyt PharmaPresent
Chairman of the supervisory board De ZorgambassadePresent
Member of the Supervisory Board Vico TherapeuticsPresent
Member Board Of Directors EvommunePresent
Member Board Of Directors Egle TherapeuticsPresent
Member Board of Directors AgomabPresent
Member Board of Directors Noema PharmaPresent
Chairman of Grant Committee EQT FoundationPresent
Partner LSPPresent
Partner EQT GroupPresent

Felice Verduyn - van Weegen's Education

VU University Amsterdam Bachelor's degree Biological Psychology
Vrije Universiteit Amsterdam (VU Amsterdam) Bachelor's degree Biological Psychology
VU University Amsterdam MsC Neurosciences
Vrije Universiteit Amsterdam (VU Amsterdam) MsC Neurosciences
Erasmus Universiteit Rotterdam MsC Neurosciences
Erasmus University Rotterdam MsC Neurosciences
Columbia University - Columbia Business School Master of Business Administration (MBA) with honors

Founders who looked at Felice Verduyn - van Weegen's profile also looked at these Scouts & Angels

Photo of Mikael Pawlo, Angel

Photo of Justin Waldron, Angel

Photo of Brad Holden, Managing Partner

Photo of Errol Damelin, Angel